Literature DB >> 32304082

Relevance of CTC Clusters in Breast Cancer Metastasis.

Roberto Piñeiro1, Inés Martínez-Pena2, Rafael López-López3,4.   

Abstract

Metastasis is the major cause of mortality in patients with breast cancer; however, the mechanisms of tumor cell dissemination and metastasis formation are not well established yet. The study of circulating tumour cells (CTCs), the metastatic precursors of distant disease, may help in this search. CTCs can be found in the blood of cancer patients as single cells or as tumor cell aggregates, known as CTC clusters. CTC clusters have differential biological features such as an enhanced survival and metastatic potential, and they hold great promises for the evaluation of prognosis, diagnosis and therapy of the metastatic cancer. The analysis of CTC clusters offers new insights into the mechanism of metastasis and can guide towards the development of new diagnostic and therapeutic strategies to suppress cancer metastasis. This has become possible thanks to the development of improved technologies for detection of CTCs and CTC clusters. However, more efficient methods are needed in order to address important questions regarding the metastatic potential of CTC and future clinical applications. In this chapter, we explore the current knowledge on the role of CTC clusters in breast cancer metastasis, their origin, metastatic advantages and clinical importance.

Entities:  

Keywords:  Breast cancer; CTC clusters; Circulating tumor cells (CTCs); Heterotypic CTC clusters; Homotypic CTC clusters; Metastatic potential

Year:  2020        PMID: 32304082     DOI: 10.1007/978-3-030-35805-1_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  A Laboratory-Friendly CTC Identification: Comparable Double-Immunocytochemistry with Triple-Immunofluorescence.

Authors:  Raed Sulaiman; Pradip De; Jennifer C Aske; Xiaoqian Lin; Adam Dale; Ethan Vaselaar; Nischal Koirala; Cheryl Ageton; Kris Gaster; Joshua Plorde; Benjamin Solomon; Bradley Thaemert; Paul Meyer; Luis Rojas Espaillat; David Starks; Nandini Dey
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

2.  Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer.

Authors:  Barbara Cardinali; Giuseppa De Luca; Roberta Tasso; Simona Coco; Anna Garuti; Giulia Buzzatti; Andrea Sciutto; Luca Arecco; Federico Villa; Franca Carli; Daniele Reverberi; Rodolfo Quarto; Mariella Dono; Lucia Del Mastro
Journal:  Int J Mol Sci       Date:  2022-06-05       Impact factor: 6.208

3.  Peripheral blood RNAseq links neutrophilic inflammation to clinical glioma metastasis.

Authors:  Yuanyuan Wu; Zhichao Fan
Journal:  BMC Med       Date:  2021-12-03       Impact factor: 8.775

Review 4.  Better together: circulating tumor cell clustering in metastatic cancer.

Authors:  Emma Schuster; Rokana Taftaf; Carolina Reduzzi; Mary K Albert; Isabel Romero-Calvo; Huiping Liu
Journal:  Trends Cancer       Date:  2021-09-01

5.  Combinatorial treatments of tamoxifen and SM6Met, an extract from Cyclopia subternata Vogel, are superior to either treatment alone in MCF-7 cells.

Authors:  Lorinda van Dyk; Nicolette J D Verhoog; Ann Louw
Journal:  Front Pharmacol       Date:  2022-09-22       Impact factor: 5.988

6.  Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer.

Authors:  Carolina Reduzzi; Serena Di Cosimo; Lorenzo Gerratana; Rosita Motta; Antonia Martinetti; Andrea Vingiani; Paolo D'Amico; Youbin Zhang; Marta Vismara; Catherine Depretto; Gianfranco Scaperrotta; Secondo Folli; Giancarlo Pruneri; Massimo Cristofanilli; Maria Grazia Daidone; Vera Cappelletti
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.